Sjögren P, Sierra-Johnson J, Gertow K, Rosell M, Vessby B, de Faire U, Hamsten A, Hellenius M-L, Fisher R M
Atherosclerosis Research Unit, Department of Medicine (Solna), Karolinska Institutet, Karolinska University Hospital, 171 76 Stockholm, Sweden.
Diabetologia. 2008 Feb;51(2):328-35. doi: 10.1007/s00125-007-0876-9. Epub 2007 Nov 20.
AIMS/HYPOTHESIS: Fatty acid desaturases introduce double bonds into growing fatty acid chains. The key desaturases in humans are Delta5-desaturase (D5D), Delta6-desaturase (D6D) and stearoyl-CoA desaturase (SCD). Animal and human data implicate hepatic desaturase activities in insulin resistance, obesity and dyslipidaemia. However, the role of desaturase activity in adipose tissue is uncertain. We therefore evaluated relationships between adipose mRNA expression, estimated desaturase activities (fatty acid ratios) in adipose tissue and insulin resistance.
Subcutaneous adipose tissue mRNA expression of D5D (also known as FADS1), D6D (also known as FADS2) and SCD was determined in 75 individuals representative of the study population of 294 healthy 63-year-old men. Desaturation indexes (product/substrate fatty acid ratios) were generated from adipose tissue fatty acid composition in all individuals. Insulin resistance was defined as the upper quartile of the updated homeostasis model assessment (HOMA-2) index.
The relevant desaturation indexes (16:1/16:0, 18:1/18:0, 20:4/20:3 and 18:3/18:2) reflected expression of SCD, but not of D5D or D6D in adipose tissue. Insulin-resistant individuals had a higher adipose tissue 18:1/18:0, but not 16:1/16:0 ratio than insulin-sensitive individuals. Individuals with a high adipose tissue 18:1/18:0 ratio were 4.4-fold (95% CI 1.8-11.8) more likely to be insulin resistant [threefold (95% CI 1.1-8.6) after adjustment for waist circumference and plasma triacylglycerol]. In a multiple regression model predicting HOMA-2, the independent effect of the 18:1/18:0 ratio was borderline (p=0.086).
CONCLUSIONS/INTERPRETATION: Adipose tissue desaturation indexes of SCD reflect the expression of the gene encoding the enzyme in this tissue. Elevated SCD activity within adipose tissue is closely coupled to the development of insulin resistance.
目的/假设:脂肪酸去饱和酶可将双键引入正在生长的脂肪酸链中。人类中的关键去饱和酶是Δ5-去饱和酶(D5D)、Δ6-去饱和酶(D6D)和硬脂酰辅酶A去饱和酶(SCD)。动物和人类数据表明肝脏去饱和酶活性与胰岛素抵抗、肥胖和血脂异常有关。然而,去饱和酶活性在脂肪组织中的作用尚不确定。因此,我们评估了脂肪组织中mRNA表达、估计的去饱和酶活性(脂肪酸比率)与胰岛素抵抗之间的关系。
在代表294名健康63岁男性研究人群的75名个体中,测定皮下脂肪组织中D5D(也称为FADS1)、D6D(也称为FADS2)和SCD的mRNA表达。根据所有个体的脂肪组织脂肪酸组成生成去饱和指数(产物/底物脂肪酸比率)。胰岛素抵抗定义为更新后的稳态模型评估(HOMA-2)指数的上四分位数。
相关去饱和指数(16:1/16:0、18:1/18:0、20:4/20:3和18:3/18:2)反映了脂肪组织中SCD的表达,但未反映D5D或D6D的表达。胰岛素抵抗个体的脂肪组织18:1/18:0比率高于胰岛素敏感个体,但16:1/16:0比率无差异。脂肪组织18:1/18:0比率高的个体发生胰岛素抵抗的可能性高4.4倍(95%CI 1.8-11.8)[调整腰围和血浆三酰甘油后为3倍(95%CI 1.1-8.6)]。在预测HOMA-2的多元回归模型中,18:1/18:0比率的独立效应接近显著(p=0.086)。
结论/解读:脂肪组织中SCD的去饱和指数反映了该组织中编码该酶的基因的表达。脂肪组织中SCD活性升高与胰岛素抵抗的发生密切相关。